Department of Medicine Annual Celebration Awards

This award recognizes scholarly clinical activity that provides enhanced patient care. 

The Med-OpS Team, led by Dr. Sheri Koshman, successfully demonstrated timely optimization of medications with improvement in patient symptoms, by utilizing a prescribing pharmacist and nurse team embedded in a specialty heart failure clinic. Notably, the Med-OpS approach has been disseminated provincially and nationally, and it is being adopted in other centres. It was also recognized with a national award.

This award recognizes the qualities of role modeling with integrity, generosity to others, and contributions to career and program development.

Several individuals contributed to Dr. Karen Kroeker's nomination. They illustrated her “extraordinary commitment to fostering excellence”, “honest and objective guidance”, “kindness and support”, “encouragement”, “advocacy”, her generosity and the profound impact she has had on their careers and lives.

“I was amazed that her only priority was my success, even if it meant her own success was delayed as a result.” 

“She has taken the time to help me understand my core values, and how these values can be used to guide me in choosing a career. She has...helped me to learn more about where my strengths lie and how to use them”.

“Dr. Kroeker is not just a mentor; she is a catalyst for growth, inspiration, and a true advocate for professional development.“

This award recognizes groups who have been successful in creating environments where these professional characteristics (cooperation, collaboration and teamwork) are effective for teaching, research, patient care and/or administration, thus representing operational role models in the academic environment and/or the larger community.

The Edmonton Diabetes & High-Risk Foot Clinic, led by Dr. Daniel Shafran, is a one-stop shop clinical model has dramatically reduced wait times for specialized diabetes care and treatment. This clinical model has enabled a superior level of cooperation, collaboration and teamwork which has led to improved clinical outcomes and has elevated the patient and caregiver experience.

Team Members: Dr. Antonia Barnes, Dr. Randeep Birdi, Kayla Chorley, Juhlii Fehr, Cathy Girard, Dr. Zandra Johnston, Dr. Kayla Lowen, Debra Luciak, Krystin Minns, Dr. Shiva Nandiwada, Freda Orr, Tawnya Perry, Dr. Daniel Shafran, Anna-Marie Van Oene

Dr. Kyle Moxham is an internal Medicine Resident (PGY2) in the Division of General Internal Medicine. His supervisor is Dr. Darren Lau. 

Award Oral Presentation: Optimizing Point-of-Care Glucose Chemstrip Utilization in Hospitalized Patients: A Quality Improvement Initiative

Authors: Kyle Moxham, Pamela Mathura, Darren Lau

Dr. Kaylin Bechard is a Senior Subspecialty Resident (R4) in the Division of Dermatology. Her supervisor is Dr. Marlene Dytoc.

Awarded Poster Presentation: Improving Patient Outcomes in the Vulvar Dermatology Clinic

Authors: Kaylin Bechard, Anita Truong, Samuel Lowe, Pamela Mathura, Reidar Hagtvedt, Marlene Dytoc

Maria-Areli Lorenzana Carrillo is a PhD Graduate Student in the Division of Cardiology. Her supervisor is Dr. Gopinath Sutendra.

Awarded Oral Presentation: Nuclear Versus Cytoplasmic/ Mitochondrial TRIM35 Signaling in Cardiomyocytes may Predict Irreversible Versus Reversible Cardiac Dysfunction and Chemotherapy-Induced Cardiotoxicity

Authors: Maria Areli Lorenzana-Carillo, Saymon Tejay, Farah Eaton, Michelle Mendiola Pla, Dawn E Bowles, John R Ussher, Evangelos Michelakis and Gopinath Sutendra

Jiyuan Piao is a Postdoctoral Fellow in the Division of Cardiology. His supervisor is Dr. Evangelos Michelakis.

Awarded Oral Presentation: A novel small molecule synthesized based on a snail hibernation model, induces hibernation in mouse fibroblasts and perfused hearts

Authors: Jiyuan Piao, Yongneng Zhang, Yuan-Yuan Zhao, Patrick Hannington, Amir Tabatabaei-Dakhili, John Ussher, Gopinath Sutendra, Evangelos Michelakis

Megan McCreary is an Internal Medicine Resident (PGY2) in the Division of General Internal Medicine. Her supervisor is Dr. Darren Lau.

Awarded Oral Presentation: SGLT-2 Inhibitor Use in Adults (Age ≥ 65) with Diabetes and Cardiovascular Disease is Lower in Alberta and Manitoba than in Ontario: A Cross-Sectional Study

Authors: Megan L. McCreary, Roseanne O. Yeung, Donna P. Manca, Michelle Greiver, Alexander G. Singer, Darren Lau

Kleouforo-Paul Dembele is a Postdoctoral Fellow in the Division of Cardiology. His supervisor is Dr. Evangelos Michelakis.

Awarded Poster Presentation: Nanotubes mediated mitochondria transfer from normal to cancer cells promotes Mesenchymal-to-Epithelial Transition (MET) needed for the establishment of metastasis in cancer

Noorossadat Seyyedi is a PhD Graduate Student in the Division of Hematology. Her supervisor is Dr. Nadia Jahroudi.

Awarded Poster Presentation: p53 associated de novo activation of VWF expression in tumor cells

Rojin Kaviani is a Senior Subspecialty Resident R5 in the Division of Preventive Medicine. Her supervisor is Dr. Ellina Lytvyak.

Awarded Poster Presentation: Prevalence of metabolic-associated steatotic liver disease (MASLD) and its impact on adverse liver outcomes in patients with primary biliary cholangitis (PBC)

This publication award is given to a scientist for a clinical investigation research publication in a top ranked journal, with the work completed at the U of A in the previous calendar year.

Dr. Carrie Ye is an Assistant Professor in the Division of Rheumatology.

Awarded Publication: Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment 

Cite: Ye C, Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson H, Harvey NC, Lorentzon M, Kanis JA. Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment. JAMA Network Open. 2023 Aug 1;6(8):e2329253-.

This award recognizes a part- or full-time clinical faculty member who is the senior or first author on a published work. This work could be original research, basic or clinical, reports on clinical trials or drug studies, or a major review article on papers published electronically and/or in hard copy in the previous calendar year.

Dr. Soori Sivakumaran is an Associate Clinical Professor in the Division of Cardiology at the University of Alberta Hospital. 

This award recognizes a publication in a top-ranked journal, with the work having been completed at the University of Alberta and where the award winner is the prinicipal investigator.

Dr. Jason Plemel is an Assistant Professor in the Division of Neurology. 

Cite: Baaklini CS, Ho MF, Lange T, Hammond BP, Panda SP, Zirngibl M, Zia S, Himmelsbach K, Rana H, Phillips B, Antoszko D. Microglia promote remyelination independent of their role in clearing myelin debris. Cell Reports. 2023 Dec 26;42(12).

This award recognizes exemplary research work that demonstrates creativity, imagination, and dedication.

It honours excellence in outstanding research contributions in scientific research and medicine.

Dr. Aldo Montano-Loza is a Professor in the Division of Gastroenterology. 

This award recognizes a member who has conceived and developed innovative products or processes, and achieved excellence in applied clinical scientific research. This member is actively engaged in research involving population or clinical epidemiology, health outcomes/health services research, or randomized control trials testing interventions or new discoveries.

Dr. Mohammed Osman is a Professor in the Division of Rheumatology. 

The Paul Man Award was named in honour of Dr. Paul Man, Division Director of Pulmonary Medicine from 1986 to 2001, for his exceptional contribution to translational research.

Jiyuan Piao is a Postdoctoral Fellow in the Division of Cardiology. His supervisor is Dr. Evangelos Michelakis.

Publication: A novel small molecule synthesized based on a snail hibernation model, induces hibernation in mouse fibroblasts and perfused hearts

Authors: Jiyuan Piao, Yongneng Zhang, Yuan-Yuan Zhao, Patrick Hannington, Amir Tabatabaei-Dakhili, John Ussher, Gopinath Sutendra, Evangelos Michelakis

Dr. Joseph Brandwein steps down from his role as Division Director and Zone lead for the Division of Hematology after an impactful tenure beginning in 2013.

Dr. Brandwein, a brilliant and respected leader, has profoundly influenced the Division. His career, marked by distinguished academic and clinical achievements, includes over 150 peer-reviewed publications and leadership in numerous clinical trials and national guidelines for leukemia treatment. 

Dr. Brandwein’s dedication to advancing clinical research in acute leukemias and hematologic malignancies has been pivotal. He has led the Adult Hematology Clinical Research Program and established the Marshall Eliuk Fund in Hematology, fostering innovation and fellowship training. His recruitment of exceptional faculty has significantly elevated the Division’s scholarship and research.

Dr. Brandwein's quiet brilliance and effective leadership will be missed, but his legacy will continue to inspire and guide the Division of Hematology. 

Dr. ​Elaine Y​acyshyn served as the Deputy Zone Clinical Department Head for the Department of Medicine from February 1, 2021 to March 31, 2024.

​During her tenure, she fostered strong academic partnerships​ and played a vital role in enhancing communication ensur​ing that important information was shared effectively, promoting transparency and engagement among department ​and zone members.

Dr. Y​acyshyn has been a dedicated educator, earning numerous awards for her teaching excellence​, including most recently, the Rheumatology residents Mentor of the Year Award.

Dr. Y​acyshyn is now serving as the Vice-Dean of Faculty Affairs, where she will continue to provide leadership and guidance for faculty and staff development, building on her legacy of service and excellence in the Department of Medicine.

Dr. Janis Miyasaki
Director, Division of Neurology, and ZCDSC
Term: 2022 - 2023

Dr. George Elleker
Interim Director, Division of Neurology, and ZCDSC
Term: 2023 - 2024

Dr. Branko Braam
Director, Division of Nephrology, and ZCDSC
Term: 2018 - 2024

Dr. Vivian Mushahwar
Interim Director, Division of Physical Medicine & Rehabilitation
Term: 2022 - 2024

The Chair's Faculty Award is the highest honour given by the Department of Medicine, recognizing outstanding service from faculty members in administrative leadership roles. This prestigious award is not given annually but is awarded at the Chair's discretion to acknowledge truly extraordinary contributions.

This year's recipient is Dr. Jacques Romney (Clinical Professor, Division of Endocrinology), whose remarkable dedication to the department has been exceptional. Jacques has consistently gone above and beyond to ensure the operational needs of the department are met. His enthusiasm, collegiality, dependability, steady hand and vast knowledge have significantly contributed to the positive atmosphere within the department.   

Affectionately called the “Chuck Morrison Award”, this award recognizes a support staff member who brings the best of themselves to work every day and continually provides exceptional service to their colleagues. This individual has an innovative and enthusiastic approach to work and is an ambassador who contributes to a positive culture within the Department of Medicine. This award was named in honour of the decades of service that Chuck Morrison provided to the DoM as the former Director of Administrative Services.

Among several deserving nominees, this year’s recipient, Giselle Prosser, was nominated by a member of the administrative services team and the nomination was supported by several members of the DoM, who noted the following:

• She has consistently proven herself to be an invaluable asset during our collaborative efforts. Her helpful nature shines through, particularly when working with our team.
• She conducts herself with the utmost integrity in all her interactions, earning the trust and respect of her colleagues.
• As a team player, she actively engages with her colleagues, fostering a collaborative environment.
• Her unwavering commitment to the Division of Pulmonary Medicine stands as a shining example of true citizenship and team spirit. In a world where loyalty and belonging are increasingly rare commodities, her devotion to her team is a beacon of hope and inspiration.
• She consistently brings the best of herself to her role, and her commitment to excellence is evident in every task she undertakes.
• During challenging times and periods of significant transition, she goes above and beyond by taking on additional responsibilities, showcasing her dedication to the success of the division.

Back to top

Dr. William Gibson, Division of Geriatric Medicine, is a clinician investigator best known for his research on incontinence in older adults, with a special focus on the association between incontinence and falls.

Dr. Gibson has contributed to clinical innovation by leading the development and implementation of a novel “in-reach” consultation model in Geriatric Medicine, which enables the proactive identification of Family Medicine patients for whom a rapid geriatric assessment would be valuable. His rural outreach geriatric service has had a positive impact on the care received by a frail and vulnerable population in the Vegreville area.

He has participated in international guideline development for incontinence in frail older adults and is an elected member of the International Continence Society’s Scientific Committee. He has a national and emerging international reputation for his research and clinical expertise.

Dr. Mohammed Osman, Division of Rheumatology, is a Clinician Investigator who developed a highly relevant and impactful research program that spans basic and translational/clinical science. His focus is identifying the underlying molecular basis of rare but serious immunological diseases (systemic sclerosis, dermatomyositis and myalgic encephalomyelitis/chronic fatigue syndrome) to develop appropriate novel patient‐oriented therapies and better diagnostics. He has established national and emerging international recognition for his research, with an outstanding publication and funding record.

Dr. Osman established the first Microvascular clinic in Western Canada for prognostication of patients with systemic sclerosis and connective tissue diseases through the use of nailfold video capillaroscopy, for which he received our Jonathan B. Meddings Clinical Innovation Award. He established a translational research clinic for systemic sclerosis and the Clinical Immunology Service call group at the UAH, which he leads. He is also Director of the Systemic Sclerosis and Microvascular Clinics at the University of Alberta.

Dr. Jason Plemel, PhD, Division of Neurology, is a Scientist whose research focuses on MS, specifically the brain’s immune cells (microglia) and understanding their beneficial and detrimental roles in MS and neuropathic pain. He received our Basic Science Publication Award for his senior author paper in the journal Molecular Neurodegeneration.

Dr. Plemel holds a Tier 2 Canada Research Chair in Glial Neuroimmunology and has an impressive funding and publication record. His work is consistently well-cited.
He has been invited to teach at the national and international level and serves on organizing committees for national and international education programs, including the Americas School of Neuroimmunology Course.

Dr. Farhad Peerani, Division of Gastroenterology, focuses on real-world efficacy of IBD treatments, mental health and IBD, IBD in the elderly, and patients with primary sclerosing cholangitis and IBD. He is the Lead for IBD Clinical Trials.

Dr. Peerani collaborated with a colleague to implement a novel Online Stress Reduction Intervention for IBD patients which has demonstrated positive impacts. He created an Elderly IBD Research and Consultation Clinic and was formally recognized by patients for his excellence as a clinician – he has received a University Hospital Foundation Champions of Care Award and a “Shine a Light” distinction from the Alberta Medical Association, recognizing physicians who go "above and beyond" in the care of their patients.

He is the Director of the IBD Fellowship Training Program and a recipient of the Division of Gastroenterology’s Teacher of the Year Award.

Dr. Jennifer Ringrose, Division of General Internal Medicine, is best known for her research in the area of blood pressure measurement, which has had international impact despite only having 20% protected time for research!

Her work led to changes in the international standard protocol for oscillometric blood pressure device validation, and international teaching and presentation opportunities.

Dr. Ringrose served as the inaugural Program Director for the GIM Subspecialty Residency Training Program and instituted a number of innovations, including introduction of a Point-of-Care-Ultrasound rotation as a core requirement of training. She received the GIM Program Mentorship Award for this work.

During her tenure, the GIM program remained the number one ranked Medicine Subspecialty in CaRMS, filling all available positions. Nationally, she helped to define Competency by Design requirements for GIM.

Dr. Ringrose has also made major contributions to clinical and administrative leadership. A couple of years ago she was appointed Division Director for GIM after a national search and selection.

Dr. Ringrose is Treasurer for the Canadian Society of Internal Medicine and will become President in 2025.

.

Dr. Patrick Pilarski, PhD, Division of Physical Medicine & Rehabilitation, is a Scientist who developed an internationally recognized research program utilizing AI to improve the functionality of upper limb robotic prosthetic devices, with the ultimate aim of making continual machine learning during human-prosthesis interactions a clinical and commercial reality.

Dr. Pilarski has many distinctions. For example, he helped to produce a new gold-standard for evaluating human use of prosthetic technologies; the Gaze and Movement Analysis (GaMA) protocol and related software, which has been used by the US Food and Drug Administration, industry, research organizations and clinics, and it is the basis for a spin-off company. He co-founded and co-led the first international research office of DeepMind, one of the most important research organizations in AI globally. Open-source releases from his laboratory are being used by research groups, rehabilitation hospitals and industry all over the world.

Dr. Pilarski held the Canada Research Chair (Tier 2) in Machine Intelligence for Rehabilitation, and he currently holds a Canadian Institute for Advanced Research (CIFAR) Chair in Artificial Intelligence.

He is a Senior Member of IEEE (Institute of Electrical and Electronics Engineers), the leading international organization for engineers, scientists and students in the computing/electronic sciences. His impact and influence extend beyond academia, e.g., he helped to present the award for Rock Album of the Year at the 2023 Juno Awards while wearing a robotic device from his laboratory. He is a founding member of the International Consortium on Rehabilitation Robotics (ICORR) and Senior Research Advisor for DeepMind UK. He provides world-class developmental opportunities to his trainees who have secured prestigious awards, competitive internships and positions with top employers.

Dr. Karen Kroeker, Division of Gastroenterology, is a Clinician Educator and leader who has made excellent contributions to educational leadership and innovation for which she is nationally recognized. She served as Program Director for the Gastroenterology Residency Training Program at the University of Alberta and helped to develop the national curriculum for Competence by Design for Gastroenterology. She received the Division of Gastroenterology Resident Appreciation Award and the Alberta Society of Gastroenterology Distinguished Educator Award.

Dr. Kroeker is Vice Chair of the Postgraduate Medical Education Academic Review Board at the U of A and Vice Chair of the Royal College Specialty Committee in Gastroenterology (she will become Chair in 2024).
She developed a special interest and expertise in the transition of care for those diagnosed with IBD in childhood/adolescence to adult gastroenterology. She has completed research projects, published articles, and developed clinics and programs in this area of interest. She also co-developed an IBD Combined Medical-Surgical Clinic to provide timely access for complex patients with IBD who may require surgery and/or post-operative care.

Dr. Frank Hoentjen, Division of Gastroenterology, came to the University of Alberta from The Netherlands in 2021. He is a Clinician Investigator who is known for his exceptional clinical and translational studies on IBD, which have changed IBD practice worldwide. A recent example includes his senior author paper in Lancet Gastroenterology and Hepatology, based on the first randomized controlled trial investigating dose de-escalation for anti-TNF (tumour necrosis factor) therapy in Crohn’s disease – this work is contributing to more cost-effective and safer disease management.

Dr. Hoentjen is a member of the Canadian IBD Research Consortium’s Scientific Committee and is Vice-Chair of Clinical Research for Crohn’s and Colitis Canada. Locally, he is Director of the IBD Unit at UAH and IBD Lead for the Edmonton Zone. In his short time at the University of Alberta, he established himself as a leader and collaborator locally, provincially and nationally. In addition, he is an engaged and effective teacher and an excellent clinician.

Back to top

Dr. Christopher Lyddell, Division of Rheumatology, is a community Rheumatologist with special interest and expertise in point-of-care Musculoskeletal Ultrasound in inflammatory joint diseases, as well as pharmacotherapy of Rheumatoid Arthritis and rehabilitation in musculoskeletal disability.

Dr. Lyddell received the 2023 Rheumatology Residency Program’s Mentor of the Year Award. He co-authored “Expert Consensus Recommendations for Musculoskeletal Ultrasound Education in Canadian Rheumatology Residency Training Programs”, which was presented at the 2023 American College of Rheumatology meeting.

Dr. Anoop Mathew, Division of Cardiology, is an Interventional Cardiologist who specializes in the emerging area of Structural Heart Interventions. He has made significant contributions to clinical innovation. In 2021, Dr. Mathew pioneered the transcatheter repair of sinus venosus atrial septal defect (first in Western Canada and second in Canada) and transcatheter closure of coronary sinus atrial septal defect (first in Canada), among other innovations.

Dr. Mathew is Research Lead for the AFC Adult Congenital Heart Disease Fellowship Program and Interventional Cardiology Lead for the Edmonton TAVR Program. He has nine peer-reviewed papers, three abstracts, a QI grant from the UHF, and many more contributions in research.

Dr. Dominic Mudiayi, Division of General Internal Medicine, is a General Internist who is passionate about QI research and education.

Dr. Mudiayi is Co-PI on a multi-year research project on GIM CaRMS and bias awareness. This work has resulted in presentations and publications. He is Co-PI of a second research project on Hospital Capacity Challenges.

He is the Liaison for the GIM Division on the Edmonton Zone Medicine Quality Council’s Strategic Clinical Improvement Committee.

Dr. Justin Okeke, Division of General Internal Medicine, is a Geriatrician and General Internist who provides clinical care at the Red Deer Regional Hospital Centre. He serves as the Site Lead for Geriatric Medicine and is the AHS Central Zone Medical Director for Seniors Health.

Dr. Okeke is Lead Preceptor for Core Geriatric Clerkship for U of A Year Four Medical Students and Lead Preceptor for U of A Family Medicine residents completing their core geriatric rotations at the Red Deer site. He has served as a peer reviewer for a leading international clinical geriatric medicine journal.

Dr. Kenneth Quadros, Division of Cardiology, is a Cardiologist with a special interest and expertise in Cardiac Electrophysiology (EP). He has advanced the complex ablation program for atrial and ventricular arrhythmias and device therapy care at the University of Alberta Hospital/Mazankowski Alberta Heart Institute and he is gaining a national reputation for his clinical skill.

He initiated and manages the Leadless Cardiac Pacing Program in Northern Alberta. He and his team successfully performed the first Micra AV leadless pacemaker implant in western Canada.

Dr. Quadros has four peer-reviewed papers and one abstract. He is the UAH Site Lead/Co-Director for the Edmonton Cardiac Arrhythmia Trials Group and Site PI for several grant-funded multicentre randomized controlled trials.

Dr. Sarah Chapelsky, Division of General Internal Medicine, is a General Internist with a special interest and expertise in obesity medicine. 

She established and serves as Medical Director for the Women’s Preoperative Weight Loss Clinic at the Lois Hole Hospital for Women.

Dr. Chapelsky has developed a regional and national reputation, with invited speaking engagements and membership on provincial and national committees. She was a member of the international Faculty for the Global Obesity Training Centre Programme. She published two peer reviewed papers and four abstracts.

Dr. Stephen Hung, Division of Physical Medicine & Rehabilitation, is a community-based Physiatrist who has a special interest and expertise in musculoskeletal medicine, interventional ultrasound and fluoroscopic guided electrodiagnostics and sports medicine.

Dr. Hung identified cancer rehabilitation as a clinical gap in Edmonton and initiated a clinical pathway between cancer rehabilitation and Physical Medicine & Rehabilitation. 

He is President-elect of the Physical Medicine & Rehabilitation Section of the Alberta Medical Association.

Dr. Jordan Marit, Division of General Internal Medicine, is a General Internist with special interest and expertise in Obstetric Medicine. 

He has leadership roles at the Royal Alexandra Hospital, including

• Physician Lead for the Diabetes in Pregnancy Program and
• Interim Resident Rotation Director for the Obstetric Medicine Program.

Dr. Marit received an Honourable Mention for UME Teacher of the Year Award in 2021.

Dr. Monika Oliver, Division of Hematology, is a Hematologist with a special interest and expertise in complement mediated disorders and Apheresis Medicine.

She is leading two large quality improvement projects and has made contributions to clinical innovation. She developed and implemented a leukopheresis protocol which has been used to successfully treat multiple patients with acute leukemia.

Dr. Oliver has four peer-reviewed publications, two abstracts, one book chapter, and is PI for three clinical trials. She is one of two provincial members of the Canadian PNH Network.

Dr. Zain Rajabali, Division of Physical Medicine & Rehabilitation, is a Physiatrist who is known for his musculoskeletal rehabilitation and interventional community-based practice.

Dr. Rajabali is part of a team of Physiatrists, orthopedic surgeons and physiotherapists who developed an interdisciplinary musculoskeletal shoulder program to reduce the assessment wait times for patients with shoulder concerns and to provide a range of management options.

e

Dr. Daniel Shafran, Division of General Internal Medicine, is a General Internist who specializes in treating patients with diabetes. He co-founded and is Medical Director for the Edmonton Diabetes & High Risk Foot Clinic - a “one-stop shop” for patients with diabetes and the only clinic in Alberta designated as both a High Risk Foot Team and an Insulin Pump Therapy Program site.

Dr. Shafran received the 2020 PGME Teacher of the Year Award (Misericordia). He is an invited member of the provincial Diabetes Working Group under the Chronic Care (Adult) Subcommittee, established by the Minister of Health.

He published an invited review, serves as Site PI for a multicentre randomized controlled trial and has obtained grant funding from JDRF Canada.

Dr. Sana Vahidy, Division of Pulmonary Medicine, is a Respirologist with a special interest and expertise in Interstitial Lung Disease (ILD).

She is a member of the clinical team that established a new one-of-a-kind Sarcoidosis Clinic in Edmonton and she facilitated the inclusion of Edmonton as a site for the Canadian Registry for Pulmonary Fibrosis.

Dr. Vahidy is a member of the Canadian Thoracic Society’s ILD Assembly. She has three peer-reviewed papers, one book chapter, one editorial, and one abstract.

Dr. Ashley Whidden, Division of Pulmonary Medicine, is a Respirologist who developed a special interest and expertise in Interstitial Lung Disease (ILD).

Dr. Whidden is the Associate Program Director and Competence Committee Chair for the Core Internal Medicine Residency Program and was involved in developing the Program’s approach to Competence by Design implementation. 

At the provincial level, she is a member of the Alberta Medical Association’s Healthy Working Environments Advisory Committee.

Dr. Ibrahim Bader, Division of Cardiology, is an Interventional Cardiologist and Co-Founder of the Heart Therapy Optimization Clinic at Edmonton Cardiology Consultants. This clinic has reduced wait times for guideline-directed heart failure therapy.

Dr. Bader provides treatment to patients in various Libyan cities while providing mentorship to young physicians — devoting between nine and 15 weeks to this work annually — a remarkable contribution to global health, in a context of humanitarian crisis and political and military instability.

He is Co-Chair of the Cardiology Medical Education Committee at the Royal Alexandra Hospital and was a member of the organizing committee for the Ninth Libyan Cardiovascular meeting.

Dr. Thirza Carpenter, Division of General Internal Medicine, has made significant leadership contributions to the General Internal Medicine and Core Internal Medicine (CIM) residency programs at the U of A. Most recently, she was appointed Program Director for CIM Residency Training Program where she oversees the second largest residency program at the U of A. Her teaching excellence was recognized with the 2021 UME Teacher of the Year Award.

Dr. Carpenter is a member of the provincial Perioperative Hyperglycemia Management Pathway Working Group.

Dr. Keysun Ranjbar, Division of Cardiology, is a Cardiologist who has made important contributions to clinical innovation. He is the Co-Founder and Co-Director of the first Renal Artery Denervation Program in Western Canada and the first community-based Heart Function Clinic in Alberta. He also developed a fully percutaneous Mitral Valve Replacement System for which he holds a patent.

Dr. Ranjbar received the 2019 UME Teacher of the Year Award and served as an interviewer for MD Program admissions. He has provided CME workshops and lectures. He served as Site PI for two multicentre clinical trials and is a peer-reviewer for an international journal.

Dr. Nikhil Shah, Division of Nephrology, is a Nephrologist who has a special interest and expertise in Home Dialysis.

He is Co-Director and Medical Lead for the Peritoneal Dialysis Unit in Alberta Kidney Care—North.

He is Co-Chair of the Provincial Working Group for Home Dialysis Therapies and Co-Lead of the Provincial Renal Connect Care Working Groups.

He is the main Clinical Knowledge Expert in Alberta Kidney Care—North for establishing Provincial Practice Direction Documents for Home Dialysis.

Dr. Shah has established local and provincial clinical innovations, including provincial Home Dialysis Connect Care workflows. He is a member and leader of several committees at the local, provincial, national and international level.

Dr. Shah received the 2021 PGME Subspecialty Teacher of the Year Award. He has six peer-reviewed papers, two abstracts, two book chapters and QI grants. He is Local PI for two CIHR-funded studies.

Dr. Fadi Khadour, Division of Cardiology, is a Cardiologist with expertise in Echocardiography. He has made significant contributions in administrative leadership.

Dr. Khadour is Site Chief for Cardiac Sciences at the Sturgeon Community Hospital. Under his leadership and advocacy, a Transesophageal echocardiogram service was recently introduced and this has positively impacted patient care. He also serves as Medical Director of the Cardiac and Device Clinics. He has seven peer-reviewed papers and has collaborated with colleagues on clinical research projects.

Dr. Elliott Sprague, Division of General Internal Medicine, is a General Internist whose excellence as an educator is ‘’’legendary’’’. He was recognized with five teaching awards in the past three years!

Dr. Sprague has had such a profound impact as an educator, that the Grey Nuns Hospital named a teaching award after him - the ‘’Dr. Sprague Esprit De Corps Award’’; given to the Senior Resident who best exemplifies his Spirit of Excellence, his enthusiasm for Internal Medicine, and his ability to bring energy and exuberance to the profession.

He has made outstanding leadership contributions as Chair of the Medical Education Committee and as the Principal Teaching Physician for residents at the Grey Nuns Hospital.

Dr. Eunice Chow, Division of Dermatology, is a Dermatologist with recognized expertise in medical hair loss, melanoma and contact dermatitis. She was recognized for her commitment and excellence in patient care with a Dermatologist of the Year Award from the Canadian Skin Patient Alliance in 2019.

Dr. Chow established a new Hair Loss Clinic and co-developed a Multidisciplinary Melanoma Care Pathway. She is Director for the Medical Hair Loss Clinic and the Pigmented Lesion Clinic and Co-Director of the Patch Test Clinic at the University Dermatology Centre. She created the ‘’Dermatology for Family Medicine Residents’’ course and served as Program Director for the Dermatology Residency Training Program for two years. She is an active member of several provincial and national committees. She has three peer-reviewed papers and one abstract.

Dr. Parbeer Grewal, Division of Dermatology, is a Dermatologist whose practice focuses primarily on Medical Dermatology. He participated in several national expert panels and co-authored Consensus Statements regarding the assessment/management of psoriasis, Prurigo Nodularis, Atopic Dermatitis and Plaque Psoriasis. He has developed proprietary products and has become one of the key opinion leaders in Canada for systemic therapy.

In his career so far, Dr. Grewal has participated in 89 clinical studies, including Phase 2, 3 and 4 clinical trials, for a range of conditions. He served as PI for 25 clinical studies (15 of which are currently active) and published 11 peer reviewed publications, a book and a book chapter. He is also an outstanding teacher.